ERBB2 and cancer: Perfusion of hot spots differed significantly between luminal A cancers and HER2-enriched cancers and between luminal A cancers and triple-negative cancers, and TTP of hot spots differed significantly between luminal A cancers and HER-2 enriched cancers (p < 0.05 for all comparisons).